NEX-I, Inc.

NEX-I, Inc.

KKRX:493410
4,275.00
KRW
0.00
(0.00%)
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

CEO
Kyung-Wan Yoon
Sector
Health technology
Industry
Pharmaceuticals: major
Address
Seoul South Korea
IPO Date
Nov 12, 2026
Business
Nex-I, Inc. engages in the development of drugs. It focuses on cancer immunotherapy. The company was founded on April 12, 2021 and is headquartered in Seoul, South Korea.